샘플 요청 목록

 카트 문의
시장보고서
상품코드
1656909

세계의 역류 방지 기기 시장 : 인사이트, 경쟁 환경, 시장 예측(-2032년)

Anti-retropulsion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
발행일: | 리서치사: DelveInsight | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

역류 방지 기기 시장 규모는 2025년부터 2032년까지 예측 기간 동안 6.69%의 연평균 복합 성장률(CAGR)로 확대될 것으로 예상됩니다. 역류 방지 기기에 대한 수요 증가는 주로 탈수와 같은 요인과 관련이 있는 신장 결석의 유병률 증가에 기인합니다. 또한, 신장 결석 발생의 중요한 위험 요인인 전립선비대증(BPH), 비만, 좌식 생활습관 등의 위험 요인에 대한 부담이 증가하고 있는 것도 시장 성장에 기여하고 있습니다. 주요 기업들의 지속적인 연구개발 노력과 함께 역류방지장치의 기술 발전도 2025년부터 2032년까지 예측 기간 동안 역류방지장치 시장의 긍정적인 성장을 가속하는 데 매우 중요한 역할을 할 것으로 보입니다.

신장결석(요로결석증) 유병률 증가는 역류방지장치 시장 확대를 촉진하는 중요한 요인으로, 2023년 10월 Kidney Research UK의 데이터에 따르면 영국에서 약 10명 중 1명이 신장결석을 앓고 있다고 합니다.

2023년 캐나다 비뇨기과 학회 자료에 따르면, 캐나다에서는 약 10명 중 1명이 일생에 한 번은 신장 결석이 발생합니다. 이 증상은 여성보다 남성에게 더 많이 발생하며, 다양한 지역에서 발병 사례가 증가하고 있습니다. 이러한 신장결석 발병률 증가는 관련 의료기기 및 치료 시장의 성장을 견인하고 있습니다. 역류 방지 기기는 신장 결석 관리, 특히 요관경 검사나 결석 분쇄 등의 시술 시 중요한 역할을 합니다. 이 장치는 치료 중 결석 조각이 신장으로 되돌아가는 것을 방지하기 위해 특별히 설계되었습니다. 전 세계적으로 신장 결석 환자 수가 증가함에 따라 역류 방지 기기를 포함한 첨단 의료 솔루션에 대한 수요는 계속 증가할 것으로 예상되며, 이는 시장 확대에 더욱 기여할 것으로 예상됩니다.

2024년 2월 세계보건기구(WHO)에 따르면 2022년에는 전 세계 10억 명 이상이 비만의 영향을 받을 것으로 예상되며, 그 중 성인 6억 5,000만 명, 청소년 3억 4,000만 명, 어린이 3억 9,000만 명으로 추산됩니다. 000만 명, 소아 3,900만 명입니다. 이 숫자는 앞으로도 증가할 것으로 예상되며, 신장 결석 치료에 대한 수요가 증가하여 시장 성장의 원동력이 될 것입니다.

그러나 장치 관련 합병증 위험, 숙련된 전문가 부족, 저소득 국가에서의 역류방지장치 접근성 제한 등의 문제가 시장 성장의 걸림돌로 작용할 수 있습니다.

세계의 역류 방지 기기 시장에 대해 조사했으며, 시장 개요와 함께 제품 유형별, 최종사용자별, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 역류 방지 기기 시장 보고서 서론

제2장 역류 방지 기기 시장 주요 요약

제3장 경쟁 구도

제4장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제5장 역류 방지 기기 시장의 주요 요인 분석

  • 역류 방지 기기 시장 성장 촉진요인
  • 역류 방지 기기 시장 성장 억제요인과 과제
  • 역류 방지 기기 시장 기회

제6장 역류 방지 기기 시장 : Porter의 Five Forces 분석

제7장 역류 방지 기기 시장 평가

  • 제품 유형별
    • 결석 포착 및 추출 장치
    • 결석 회수 장치
    • 기타
  • 최종사용자별
    • 병원
    • 외래수술센터(ASC)
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 기타 지역

제8장 역류 방지 기기 시장 기업과 제품 개요

  • Boston Scientific Corporation
  • Cook
  • Rocamed
  • Accordion Medical
  • EndoTheia, Inc.
  • KARL STORZ
  • Olympus Corporation
  • Coloplast Group
  • Endotherapeutics Pty Ltd.
  • ELMED Medical Systems
  • PENTAX Medical
  • UROMED Kurt Drews KG
  • BD
  • Dornier MedTech
  • NeoScope Inc.
  • OTU Medical
  • Clarion Medical Technologies
  • Calyxo, Inc.
  • EMS Urology
  • Happiness Works Medical

제9장 KOL(Key Opinion Leader)의 견해

제10장 프로젝트 접근

제11장 DelveInsight에 대해

제12장 면책사항과 문의

LSH 25.03.06

Anti-retropulsion Devices Market by Product Type (Stone Entrapment and Extraction Devices, Stone Retrieval Devices, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 due to the growing prevalence of kidney stones and increasing R&D activiites and product launches in anti-retropulsion devices.

The anti-retropulsion devices market is estimated to grow at a CAGR of 6.69% during the forecast period from 2025 to 2032. The increasing demand for anti-retropulsion devices is primarily driven by the rising prevalence of kidney stones which are often linked to factors like dehydration. Additionally, the growing burden of risk factors such as benign prostatic hyperplasia (BPH), obesity, and sedentary lifestyles, both of which are significant risk factors for the development of kidney stones, further contribute to the market's growth. Technological advancements in anti-retropulsion devices, along with ongoing research and development efforts by key players, are also playing a pivotal role in propelling the positive growth of the anti-retropulsion devices market during the forecast period from 2025 to 2032.

Anti-retropulsion Devices Market Dynamics:

The growing prevalence of kidney stones (urolithiasis) is a key factor driving the expansion of the anti-retropulsion devices market. According to Kidney Research UK data from October 2023, kidney stones affect approximately one in ten individuals in the United Kingdom.

According to data from the Canadian Urological Association in 2023, approximately one in ten people develop a kidney stone at some point in their life in Canada. This condition is more prevalent in men than in women, with active cases on the rise in various regions. This increasing incidence of kidney stones is driving the growth of the market for related medical devices and treatments. Anti-retropulsion devices play a critical role in the management of kidney stones, particularly during procedures like ureteroscopy and lithotripsy. These devices are specifically designed to prevent the migration of stone fragments back into the kidney during treatment. With the growing number of kidney stone cases worldwide, the demand for advanced medical solutions, including anti-retropulsion devices, is expected to continue rising, further contributing to the market's expansion.

The growing incidence of obesity and sedentary lifestyles-key risk factors for kidney stones-further drives market growth. According to the World Health Organization (WHO) in February 2024, over 1 billion people worldwide were affected by obesity in 2022, including 650 million adults, 340 million adolescents, and 39 million children. This number is expected to rise, creating a greater demand for kidney stone treatments, thereby driving the market growth.

However, challenges such as the risk of device-related complications, lack of skilled professionals, and limited access to anti-retropulsion devices in low-income countries may act as barriers to market growth.

Anti-retropulsion Devices Market Segment Analysis:

Anti-retropulsion Devices Market by Product Type (Stone Entrapment and Extraction Devices, Stone Retrieval Devices, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the anti-retropulsion devices, stone entrapment and extraction devices are expected to capture the largest market share during the forecast period. The is attributed to various advantages associated with these devices. Stone entrapment and extraction devices are highly effective tools for removing kidney stones from the urinary tract, while also minimizing the risk of stone migration.

These devices offer minimally invasive solutions, meaning smaller incisions or no incisions at all, which results in less pain, a lower risk of infection, and quicker recovery times compared to traditional open surgery. For larger stones or those located in difficult-to-reach areas, stone extraction through entrapment proves to be particularly beneficial. These devices are designed to fragment stones into smaller pieces, making them easier to remove or pass naturally, reducing the need for more invasive procedures. This approach not only improves patient comfort but also contributes to more efficient treatment outcomes, promoting faster recovery and preserving overall kidney function.

Stone entrapment and extraction devices also play a crucial role in preventing the proximal migration of stones and fragments during ureteroscopy. This is essential for maintaining visibility and access to the stone, ensuring that the procedure is efficient and reduces the risk of complications associated with stone migration back into the kidney. For instance, devices like the EscapeTM Nitinol Stone Retrieval Device by Boston Scientific are specifically designed to facilitate smoother procedures by minimizing retropulsion, a common issue that can lead to longer operative times and increased procedure complexity.

In addition, the innovative technologies within the stone entrapment and extraction devices category, combined with their growing applications in urological procedures, are expected to significantly drive market growth. As the demand for more effective treatment solutions increases, the anti-retropulsion devices market is set to expand further throughout the forecast period.

North America is expected to dominate the overall anti-retropulsion devices market:

North America is projected to dominate the anti-retropulsion devices market during the forecast period from 2025 to 2032. This growth can be attributed to several critical drivers, including the increasing incidence of kidney stones and urinary cancers, as well as a rise in risk factors associated with kidney stone formation. Furthermore, advancements in technology related to the development of anti-retropulsion devices, coupled with a strong healthcare infrastructure, are expected to significantly propel market expansion in the region.

According to data from the American Kidney Fund (2024), over 1 in 10 men and approximately 1 in 14 women in the United States experienced kidney stones at least once in their lifetime. Additionally, data from the National Institutes of Health (NIH) in 2023 highlighted that kidney stone affects 1 in 11 people, with an estimated 600,000 new cases reported in the United States annually. The rising prevalence of kidney stones is significantly driving the growth of the anti-retropulsion devices market in the region.

The increasing incidence of upper tract urothelial carcinoma (UTUC) and kidney diseases is also a significant driver for the growing demand for anti-retropulsion devices. Patients with urinary cancers and other urinary tract conditions face an elevated risk of developing renal stones, exacerbating the need for effective anti-retropulsion interventions. According to data from the Center for Disease Control and Prevention (CDC) published in June 2024, approximately 35 million cases of chronic kidney disease (CKD) were reported in the United States in 2023. CKD impairs kidney function, leading to the formation and accumulation of renal stones, thereby fueling demand for anti-retropulsion devices and promoting market expansion.

Anti-retropulsion Devices Market Key Players:

Some of the key market players operating in the anti-retropulsion devices market include Boston Scientific Corporation, Cook, Rocamed, Accordion Medical, EndoTheia, Inc., KARL STORZ, Olympus Corporation, Coloplast Group, Endotherapeutics Pty Ltd., ELMED Medical Systems, PENTAX Medical, UROMED Kurt Drews KG, BD, Dornier MedTech, NeoScope Inc., OTU Medical, Clarion Medical Technologies, Calyxo, Inc., EMS Urology, Happiness Works Medical, and others.

Recent Developmental Activities in the Anti-retropulsion Devices Market:

  • In November 2024, EndoTheia, Inc., a frontrunner in innovative surgical technology, announced the successful completion of the first-in-human clinical trial for its FlexStone(TM) Basket. The cutting-edge device provides unmatched flexibility and control, allowing for the retrieval of stones from difficult-to-reach and challenging locations, thereby enhancing the precision and effectiveness of stone removal procedures. The success of this trial marked a significant milestone in advancing minimally invasive treatments for kidney stones.

Key Takeaways from the Anti-retropulsion Devices Market Report Study

  • Market size analysis for current Anti-retropulsion Devices Market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the Anti-retropulsion Devices market.
  • Various opportunities are available for the other competitors in the Anti-retropulsion Devices Market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current Anti-retropulsion Devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Anti-retropulsion Devices market growth in the coming future?

Target Audience who can be benefited from this Anti-retropulsion Devices Market Report Study

  • Anti-retropulsion Devices product providers
  • Research organizations and consulting companies
  • Anti-retropulsion Devices related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Anti-retropulsion Devices
  • Various end-users who want to know more about the Anti-retropulsion Devices Market and the latest technological developments in the Anti-retropulsion Devices Market.

Frequently Asked Questions for the Anti-retropulsion Devices Market:

1. What are Anti-retropulsion Devices?

  • Anti-retropulsion devices for kidney stones are medical instruments designed to prevent the backward movement (retropulsion) of kidney stones during minimally invasive procedures, such as ureteroscopy or lithotripsy. When a stone is being fragmented or removed, there is a risk that it could move away from the targeted area, potentially causing complications or making the procedure less effective.

2. What is the market for ureteroscopes?

  • The anti-retropulsion devices market is estimated to grow at a CAGR of 6.69% during the forecast period from 2025 to 2032.

3. What are the drivers for the Anti-retropulsion Devices market?

  • The increasing demand for anti-retropulsion devices is primarily driven by the rising prevalence of kidney stones which are often linked to factors like dehydration. Additionally, the growing burden of risk factors such as benign prostatic hyperplasia (BPH), obesity, and sedentary lifestyles, both of which are significant risk factors for the development of kidney stones, further contribute to the market's growth. Technological advancements in anti-retropulsion devices, along with ongoing research and development efforts by key players, are also playing a pivotal role in propelling the positive growth of the anti-retropulsion devices market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the Anti-retropulsion Devices market?

  • Some of the key market players operating in the anti-retropulsion devices market include Boston Scientific Corporation, Cook, Rocamed, Accordion Medical, EndoTheia, Inc., KARL STORZ, Olympus Corporation, Coloplast Group, Endotherapeutics Pty Ltd., ELMED Medical Systems, PENTAX Medical, UROMED Kurt Drews KG, BD, Dornier MedTech, NeoScope Inc., OTU Medical, Clarion Medical Technologies, Calyxo, Inc., EMS Urology, Happiness Works Medical, and others.

5. Which region has the highest share in the Anti-retropulsion Devices market?

  • North America is projected to dominate the ureteroscope market during the forecast period from 2025 to 2032. This growth can be attributed to several critical drivers, including the increasing incidence of kidney stones and urinary cancers, as well as a rise in risk factors associated with kidney stone formation. Furthermore, advancements in technology related to the development of anti-retropulsion devices, coupled with a strong healthcare infrastructure, are expected to significantly propel market expansion in the region.

Table of Contents

1. Anti-retropulsion Devices Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Anti-retropulsion Devices Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Anti-retropulsion Devices Market Key Factors Analysis

  • 5.1. Anti-retropulsion Devices Market Drivers
    • 5.1.1. The growing prevalence of kidney stones
    • 5.1.2. The growing burden of risk factors such as benign prostatic hyperplasia (BPH), obesity, and sedentary lifestyles
    • 5.1.3. Technological advancements in anti-retropulsion devices, along with ongoing research and development efforts by key players
  • 5.2. Anti-retropulsion Devices Market Restraints and Challenges
    • 5.2.1. Risks of device-associated complications
    • 5.2.2. Lack of skilled professionals, and limited access to anti-retropulsion devices in low-income countries
  • 5.3. Anti-retropulsion Devices Market Opportunity
    • 5.3.1. Shift towards minimally invasive procedures

6. Anti-retropulsion Devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Anti-retropulsion Devices Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Stone Entrapment and Extraction Devices
    • 7.1.2. Stone Retrieval Devices
    • 7.1.3. Others
  • 7.2. By End-User
    • 7.2.1. Hospitals
    • 7.2.2. Ambulatory Surgical Centers
    • 7.2.3. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.1.2. Canada Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.1.3. Mexico Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.2. Europe
      • 7.3.2.1. France Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.2.2. Germany Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.2.3. United Kingdom Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.2.4. Italy Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.2.5. Spain Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.2.6. Rest of Europe Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.3.2. Japan Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.3.3. India Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.3.4. Australia Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.3.5. South Korea Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.3.6. Rest of Asia-Pacific Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.4.2. Africa Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.4.3. South America Anti-retropulsion Devices Market Size In USD Million (2022-2032)

8. Anti-retropulsion Devices Market Company and Product Profiles

  • 8.1. Boston Scientific Corporation
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Cook
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Rocamed
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Accordion Medical
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. EndoTheia, Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. KARL STORZ
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Olympus Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Coloplast Group
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Endotherapeutics Pty Ltd.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. ELMED Medical Systems
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. PENTAX Medical
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. UROMED Kurt Drews KG
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. BD
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Dornier MedTech
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. NeoScope Inc.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. OTU Medical
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Clarion Medical Technologies
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Calyxo, Inc.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. EMS Urology
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Happiness Works Medical
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제